These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 831074)

  • 1. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.
    Toyka KV; Drachman DB; Griffin DE; Pestronk A; Winkelstein JA; Fishbeck KH; Kao I
    N Engl J Med; 1977 Jan; 296(3):125-31. PubMed ID: 831074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A transferable "myasthenogenic" factor in the serum of patients with myasthenia gravis (author's transl)].
    Toyka KV; Drachman DB; Pestronk A; Fischbeck H; Kao I
    J Neurol; 1976 Jun; 212(3):271-80. PubMed ID: 58978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
    Tüzün E; Saini SS; Ghosh S; Rowin J; Meriggioli MN; Christadoss P
    Neuromuscul Disord; 2006 Feb; 16(2):137-43. PubMed ID: 16427283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive transfer of seronegative myasthenia gravis to mice.
    Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
    Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of myasthenia gravis as a disorder of acetylcholine receptors.
    Drachman DB; Pestronk A; Stanley EF
    Adv Cytopharmacol; 1979; 3():237-44. PubMed ID: 382787
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis: passive transfer from man to mouse.
    Toyka KV; Brachman DB; Pestronk A; Kao I
    Science; 1975 Oct; 190(4212):397-9. PubMed ID: 1179220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid molecules.
    Sterz R; Hohlfeld R; Rajki K; Kaul M; Heininger K; Peper K; Toyka KV
    Muscle Nerve; 1986 May; 9(4):306-12. PubMed ID: 2423869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.
    Biesecker G; Gomez CM
    J Immunol; 1989 Apr; 142(8):2654-9. PubMed ID: 2703710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
    Burres SA; Crayton JW; Gomez CM; Richman DP
    Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes.
    Richman DP; Patrick J; Arnason BG
    N Engl J Med; 1976 Mar; 294(13):694-8. PubMed ID: 129705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis (first of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
    [No Abstract]   [Full Text] [Related]  

  • 14. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
    Kim YI
    Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis.
    Mittag T; Kornfeld P; Tormay A; Woo C
    N Engl J Med; 1976 Mar; 294(13):691-4. PubMed ID: 1250280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.
    Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis.
    Abramsky O; Aharonov A; Webb C; Fuchs S
    Clin Exp Immunol; 1975 Jan; 19(1):11-6. PubMed ID: 1239345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
    Corey AL; Richman DP; Agius MA; Wollmann RL
    J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1.
    Simpson JA
    Muscle Nerve; 1978; 1(1):45-56. PubMed ID: 377070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.